Clinical Trial Update: G7 Dual Mobility With Vivacit-E or Longevity PMCF [NA]

View source ↗

Summary

Clinical trial update indicating Zimmer Biomet's G7 Dual Mobility hip system with Vivacit-E or Longevity PMCF is currently enrolling by invitation for various h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avascular Necrosis of the Femoral Head
• Dislocation of the Hip
• Femoral Neck Fracture
• Hip Osteoarthritis
• Revision Hip Arthroplasty
• Rheumatoid Arthritis
• Trochanteric Fracture of the Femur

Drugs mentioned

• G7 Dual Mobility Hip System with Longevity PMCF
• G7 Dual Mobility Hip System with Vivacit-E coating

Snippet

Sponsor: Zimmer Biomet | Conditions: Hip Osteoarthritis, Rheumatoid Arthritis | NA | Status: ENROLLING_BY_INVITATION